Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization.

AIDS research and human retroviruses - 1 May 2001

Dyrhol-Riise A M, Voltersvik P, Berg O G, Olofsson J, Kleivbo S, Asjö B

Abstract excerpt

HIV-1 can persist in infected patients despite undetectable plasma viremia. To characterize the residual viral load, repetitive blood and tonsillar samples were collected from 11 HIV-1-positive individuals before and during 96 weeks of therapy with zidovudine, lamivudine, and indinavir. HIV-1 RNA in tonsils was quantified by RT-PCR and infectious HIV-1 provirus by the limiting dilution assay. Genotypic resistance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to HIV Protease Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Indinavir

Share to Lamivudine

Share to Lymphoid Tissue

Share to Proviruses

Share to Viremia

Share to Zidovudine

Source

Identifiers

PMID: 11375053
DOI: 10.1089/088922201300119671

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization.PMID 11375053Read ↗

Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4 <sup>+</sup> T CellsSemantic proximity Read ↗

HIV-1 latent reservoir size and diversity are stable following brief treatment interruption.Semantic proximity Read ↗

Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral TherapySemantic proximity Read ↗

HIV-1 persistence during ARTSemantic proximity Read ↗

Clonal Sequences Recovered from Plasma from Patients with Residual HIV-1 Viremia and on Intensified Antiretroviral Therapy Are Identical to Replicating Viral RNAs Recovered from Circulating Resting CD4 <sup>+</sup> T CellsSemantic proximity Read ↗

Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.Semantic proximity Read ↗

Defective HIV-1 proviruses produce viral proteinsSemantic proximity Read ↗

Residual Viremia in Treated HIV+ IndividualsSemantic proximity Read ↗

Varied Patterns of Decay of Intact Human Immunodeficiency Virus Type 1 Proviruses Over 2 Decades of Antiretroviral TherapySemantic proximity Read ↗

In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays from 50 to <5 Copies per Milliliter, with a Half-Life of 6 MonthsSemantic proximity Read ↗

Quantitation of Replication-Competent HIV-1 in Populations of Resting CD4 + T CellsSemantic proximity Read ↗

Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.